Cellular-Resolution Imaging of Bystander Payload Tissue Penetration from Antibody-Drug Conjugates
After several notable clinical failures in early generations, antibody-drug conjugates (ADC) have made significant gains with seven new FDA approvals within the last 3 years. These successes have been driven by a shift towards mechanistically informed ADC design, where the payload, linker, drug-to-a...
Gespeichert in:
Veröffentlicht in: | Molecular cancer therapeutics 2022-02, Vol.21 (2), p.310-321 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!